跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,648 条关于
“Vaderis Therapeutics”
全部
16,648
临床试验
3,595
药物
3,119
机构
1,124
资讯
8,810
上个月
Vaderis Therapeutics Secures $152M Series B, Launches Phase 3 HEROIC Trial of Engasertib for HHT
2年前
Vaderis' VAD044 Shows Promise in Hereditary Hemorrhagic Telangiectasia Trial
3个月前
Vaderis Raises $152 Million to Fund Phase 3 Trial of AKT Inhibitor Engasertib in Hereditary Haemorrhagic Telangiectasia
去年
Vaderis' VAD044 Receives FDA Fast Track Designation for Hereditary Hemorrhagic Telangiectasia
2个月前
Vaderis Launches Global Phase 3 HEROIC Trial of Engasertib for Hereditary Hemorrhagic Telangiectasia
9个月前
Engasertib Shows Promise in First Controlled Trial for Hereditary Hemorrhagic Telangiectasia
去年
Aravax Strengthens Leadership Team with Regulatory Expert Louise Peacock Ahead of Phase 3 Peanut Allergy Trial
去年
Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition
去年
Valerio Therapeutics Halts Clinical Trials, Pivots to Early-Stage Drug Development
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
第 1 页,共 881 页
上一页
下一页